How medtech engineers actually get hired in Sydney

The Australian medtech scene is small enough that almost every senior engineering hire happens through relationships, not applications. That statement sounds like the empty framing every recruiter offers, but the numbers back it. Cochlear, ResMed and Saluda together employ most of the senior engineering talent in the country. The Sydney scaleup tier - firms with Series A / B funding building implantable, wearable or diagnostic devices - absorbs most of the remainder. Almost everyone in the market knows almost everyone else. The interesting roles rarely get advertised.

Here is how it actually works, and what to do about it.

The visible market and the invisible market

The visible market is the ads you see on Seek or LinkedIn. Most of them are mid-level roles. When a senior role hits the visible market, it usually means one of two things: either the internal referral network came up empty and the hire is now urgent, or the firm has a genuine specialism gap and no relationship to draw on. Neither of those framings is a problem in itself. But the visible market is the tail end of the process, not the middle.

The invisible market is everything else. A senior Firmware Engineer at Cochlear finishes a project. Their old team lead has since moved to a Series-B implantables firm. A message goes between them. A conversation follows. Two months later there is a signed contract. That role never appeared on a job board.

If you are a senior engineer inside Australian medtech and you have only ever engaged with the visible market, you have been operating in about ten per cent of the actual opportunity set.

What you can do about it

The advice below is unromantic. But it works.

Get named as someone worth calling. Recruiters covering this market build target lists of maybe fifty candidates per specialism. Being on the list is what causes the call to happen when the right brief lands. To be on the list you need to be legible - meaning your LinkedIn shows enough specificity that a recruiter can see the shape of your work, and your name has come up in enough conversations that a recruiter has heard it more than once. Neither of those requires hustle. Both require deliberate consistency.

Do not chase every conversation. The single biggest reason candidates lose credibility with recruiters in this market is that they take every call and respond to every message. The result is that recruiters stop treating you as a serious signal. Pick two or three recruiters who cover the medtech market properly, take their calls, and let the rest go to voicemail. Word travels.

Bring evidence to your first conversation. The candidate who arrives at a first call with a specific view - the project they are proudest of, the piece of the regulatory pathway they most enjoy owning, the class of problem they will never take again - always outperforms the candidate who arrives asking what is out there. Recruiters remember specificity. Vague candidates get vague follow-ups.

Watch the middle tier, not the top. Cochlear and ResMed are the visible ceiling of Australian medtech, but the more interesting career shifts happen at the tier below - firms in the twenty-to-two-hundred-headcount range, still shipping to first commercial customers. Those firms hire less frequently but pay closer attention to the profile of who they take. The signal on a well-run Series-B hire is meaningfully higher than a mid-level role at a prime.

What “great” looks like at intake

When we run a senior medtech search we look for a small number of things. The candidate has shipped commercially into a regulated environment. The candidate holds both the engineering language and the QMS / regulatory language. The candidate can articulate why the company they are joining is the right next step, not just the next step. Candidates who arrive already able to talk in those terms usually close on their next role inside twelve weeks. Candidates who arrive still figuring it out usually take longer, and take positions that turn out to be less good fits.

The Sydney medtech market rewards patience and specificity. It does not reward hustle. If you are underestimating either, adjust.